Bayobay, Khalil Kent .
HRN: 21-83-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
12/15/2022
12/17/2022
PO
1.5 Ml
OD
ATP, URTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes